| Kabiven emulsion for infusion PA2059/045/003 |
Soya bean oil, Glucose monohydrate, Alanine, Arginine, Aspartic Acid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Kabiven Peripheral emulsion for infusion PA2059/045/004 |
Soya bean oil, Alanine, Aspartic Acid, Glutamic acid, Glycine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Kacital 1080 mg modified-release tablets PA23382/002/001 |
Potassium citrate |
XGX Pharma ApS |
Not marketed |
| Kadcyla 100 mg powder for concentrate for solution for infusion EU/1/13/885/001 |
Trastuzumab emtansine |
Roche Registration GmbH |
— |
| Kadcyla 160 mg powder for concentrate for solution for infusion EU/1/13/885/002 |
Trastuzumab emtansine |
Roche Registration GmbH |
— |
| Kaftrio 37.5 mg/25 mg/50 mg film-coated tablets EU/1/20/1468/002 |
Ivacaftor, TEZACAFTOR, Elexacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kaftrio 60 mg/40 mg/80 mg granules in sachet EU/1/20/1468/003 |
Elexacaftor, TEZACAFTOR, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kaftrio 75 mg/50 mg/100 mg film-coated tablets EU/1/20/1468/001 |
TEZACAFTOR, Ivacaftor, VX-445 |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kaftrio 75 mg/50 mg/100 mg granules in sachet EU/1/20/1468/004 |
Elexacaftor, TEZACAFTOR, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalcipos-D forte 500 mg/800 IU chewable tablets PA25506/011/002 |
Calcium, Vitamin d3 |
Cooper Consumer Health B.V. |
Marketed |
| Kalcipos-D forte 500 mg/800 IU film-coated tablets PA25506/011/001 |
Calcium, Cholecalciferol |
Cooper Consumer Health B.V. |
Marketed |
| Kaletra EU/1/01/172/4-5,7-8 |
Lopinavir, Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra (80 mg + 20 mg)/ml oral solution EU/1/01/172/003 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra 100 mg/25 mg film-coated tablets EU/1/01/172/006 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kalms Day film-coated tablets TR22702/002/001 |
|
LanesHealth (Ireland) Limited |
— |
| Kalms Night Film-Coated Tablets TR22702/001/001 |
|
LanesHealth (Ireland) Limited |
— |
| Kalydeco 13.4 mg granules in sachet EU/1/12/782/010-011 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 150 mg film-coated tablets EU/1/12/782/001-002 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 150 mg film-coated tablets EU/1/12/782/005 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 50 mg granules in sachet EU/1/12/782/003 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 59.5 mg granules in sachet EU/1/12/782/008 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 75 mg film-coated tablets EU/1/12/782/007 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kalydeco 75 mg granules in sachet EU/1/12/782/004 |
Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Kamiren 4 mg prolonged-release tablets PA1347/038/001 |
Doxazosin |
KRKA, d.d., Novo mesto |
Marketed |
| KANJINTI 150 mg powder for concentrate for solution for infusion EU/1/18/1281/001 |
Trastuzumab |
Amgen Europe B.V. |
— |
| KANJINTI 420 mg powder for concentrate for solution for infusion EU/1/18/1281/002 |
Trastuzumab |
Amgen Europe B.V. |
— |
| KANUMA 2 mg/ml concentrate for solution for infusion EU/1/15/1033/001 |
Sebelipase alfa |
Alexion Europe SAS |
— |
| Kapake 15mg/500mg Tablets PA1418/020/001 |
Paracetamol, Codeine phosphate hemihydrate |
Athlone Pharmaceuticals Limited |
Not marketed |
| Kapake 30 mg/500 mg Tablets PA1418/020/002 |
Paracetamol, Codeine phosphate hemihydrate |
Athlone Pharmaceuticals Limited |
Not marketed |
| Kapruvia 50 micrograms/mL solution for injection EU/1/22/1643/001-002 |
Difelikefalin Acetate |
Vifor France |
— |
| Karvea 150 mg film-coated tablets EU/1/97/049/021-025 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 150 mg tablets EU/1/97/049/004-006 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 300 mg film-coated tablets EU/1/97/049/026-030 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 300 mg tablets EU/1/97/049/007-009 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 75 mg film-coated tablets EU/1/97/049/016-020 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvea 75 mg tablets EU/1/97/049/001-003 |
Irbesartan |
Sanofi Winthrop Industrie |
— |
| Karvezide 150 mg/12.5 mg film-coated tablets EU/1/98/085/011-015 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 150 mg/12.5 mg tablets EU/1/98/085/001-003 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/12.5 mg film-coated tablets EU/1/98/085/016-020 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/12.5 mg tablets. EU/1/98/085/004-006 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Karvezide 300 mg/25 mg film-coated tablets EU/1/98/085/023-028 |
Irbesartan, Hydrochlorothiazide |
Sanofi Winthrop Industrie |
— |
| Kauliv 20 micrograms/80 microliters solution for injection EU/1/22/1710/001-002 |
Teriparatide |
Strides Pharma (Cyprus) Limited |
— |
| KAVIGALE 300 mg solution for injection/infusion EU/1/24/1900/001 |
Sipavibart |
AstraZeneca AB |
— |
| Kay-Cee-L Syrup 7.5% w/v PA22697/026/001 |
Potassium chloride |
Syri Pharma Limited t/a Thame Laboratories |
Marketed |
| KAYFANDA 1200 microgram hard capsules EU/1/24/1854/004 |
Odevixibat |
Ipsen Pharma |
— |
| KAYFANDA 200 microgram hard capsules EU/1/24/1854/001 |
Odevixibat |
Ipsen Pharma |
— |
| KAYFANDA 400 microgram hard capsules EU/1/24/1854/002 |
Odevixibat |
Ipsen Pharma |
— |
| KAYFANDA 600 microgram hard capsules EU/1/24/1854/003 |
Odevixibat |
Ipsen Pharma |
— |
| Kefdensis 60 mg solution for injection in pre-filled syringe EU/1/25/1980/001 |
Denosumab |
Stada Arzneimittel AG |
— |
| Keflex 125 mg/5 ml Powder for Oral Suspension PA1226/002/002 |
Cephalexin monohydrate |
Flynn Pharma Limited |
Marketed |